Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

New Stock Coverage: Save the Last Dance for SFX Entertainment


Wall Street ratings agencies set the tone for today's stock market.

Double, Double, Toil and Trouble‏? Not so much. US stocks rose on Halloween week, even as a man named Delwiche warned of a weak economy and one of The Munsters waxed lyrical on Apple (NASDAQ:AAPL). Thus, markets advanced for the fourth straight week, with US stocks hitting fresh historic peaks. (Not all stocks share in the ebullience - financials fell to lead industry laggards, with JP Morgan (NYSE:JPM) unfortunately unable to use a witch's broom to sweep its ever-increasing skeletons under the carpet.) With the S&P 500 Index (INDEXSP:.INX) up where the air is clear, Spirit Airlines (NASDAQ:SAVE) surged 2.3% and Spirit Aerosystems (NYSE:SPR) levitated 8.23%; "I ain't afraid of no ghost", to quote an famous poltergeist film from 1984. That was the year an iconic computer company arrived on the scene, but Dell didn't need Adele to tell it the fat lady finally sang. It is indeed over for the Texas tech titan, at least as a tradable entity.

In terms of events that may move markets today, at 10:00 a.m. Eastern August and September factory orders are each released. On the earnings front, several specific stocks could be impacted by quarterly earnings announcements. These include Anadarko Petroleum (NYSE:APC), CF Industries (NYSE:CF), Goodrich Petroleum (NYSE:GDP), Hertz (NYSE:HTZ), HSBC Holdings (NYSE:HBC), Kellogg (NYSE:K), Marathon Oil (NYSE:MRO), Office Depot (NYSE:ODP), OfficeMax (NYSE:OMX), Pioneer Natural Resources (NYSE:PXD), Plains All American Pipeline (NYSE:PAA), and Tenet Healthcare (NYSE:THC).

Antero Resources (NYSE:AR): Shares are begun with an Overweight at Barclays, whose target price is $63.

Cell Therapeutics (NASDAQ:CTIC): Cell Therapeutics shares slumped 7.39% on Friday but there is better news for the microcap biotech this morning. It is begun with a bullish Buy at boutique broker H.C. Wainwright. Stock in Cell Therapeutics is still in the green to the tune of 7.95% over the past year, however.

Gigamon (NYSE:GIMO): Pacific Crest picks the networking name up at Outperform.

LDR Holding (NASDAQ:LDHR): Shares get assigned an Overweight with Piper Jaffray.

MacroGenics (NASDAQ:MGNX): Bank of America-Merrill Lynch launches Neutral-rated research.

QTS Realty Trust (NYSE:QTS): The stock is begun with a Buy at Jefferies.

SFX Entertainment (NASDAQ:SFXE): Shares are begun with bullish Buys at both Jefferies and UBS, whose respective price objectives are $16 and $15. SFX Entertainment, a recent initial public offering, produces dance music events worldwide. SFX Entertainment's exclusive offerings include Tomorrowland and Life in Color. (It is a manic Monday for the firm, for minutes ago, SFX Entertainment acquired Made Event, which created the Electric Zoo festival.)

Twitter (NYSE:TWTR): Twitter hasn't even gone public yet, but on Wall Street, it is never too early to be bullish. Today Twitter is established with an upbeat Overweight at Atlantic Equities.

Western Refining Logistics (NYSE:WNRL): The limited partnership is launched with an Outperform recommendation and $28 target at Credit Suisse.

(See also: Stock Upgrades: Party On, Red Sox Nation. Boston Beer Gets a Boost and Stock Downgrades: Aflac's Duck Dynasty Is Over)
< Previous
  • 1
Next >
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos